SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Fyodor Dostoevsky — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientFyodor Dostoevsky
Date of birth1821-11-11
IdentifiersMRN HR-NI018-SYN-TD; SSN (made up) 000-18-3907
Document date1865-05-05
AuthorAgnes Lindahl, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-month review on lamotrigine, with a trough level. [S]

History of Present Illness

Mr. Dostoevsky returns nine weeks after starting lamotrigine; he has taken 100 mg twice daily for three weeks. He had one generalized seizure in the third week of the titration, while on 50 mg a day, after a night without sleep to finish a manuscript; a friend who was with him timed it at about two minutes and followed the seizure action plan. He has had none since reaching 150 mg a day. He has had no rash, mouth sores, or fever, and no dizziness or double vision. The sleep-deprived EEG six weeks ago was normal. He has not gambled. He has attended every weekly therapy session and is learning to spot the thoughts that lead him to chase losses. He went to two Gamblers Anonymous meetings and saw the debt counselor, who is drawing up a repayment plan. His mood is better. He has no thoughts of suicide. [S]

ElementDetail
SeizuresOne in week three of the titration, after sleep loss; none since
Lamotrigine100 mg twice daily for three weeks; no rash or other side effects
GamblingNone for nine weeks; therapy weekly
MoodPHQ-9 6

Review of Systems

SystemResultFinding
NeurologicalPositiveOne seizure in week three of the titration; no dizziness, double vision, or unsteadiness
IntegumentaryNegativeNo rash or mouth sores
PsychiatricNegativeMood better; fewer urges; no thoughts of suicide or self-harm

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Lamotrigine 25 mg tablets, slow titration: 25 mg once daily for weeks 1 and 2, 50 mg once daily for weeks 3 and 4, 50 mg twice daily for week 5, and 75 mg twice daily for week 625 mg once daily, increased every two weeks and then weekly as written, to 75 mg twice daily in week 6Oral route1865-03-03 to 1865-04-13completedS
Lamotrigine 100 mg tablet, one tablet twice daily100 mg twice daily (200 mg a day), 30-day supply at a timeOral route1865-04-14activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1865-05-05Body height170cmS
1865-05-05Body weight68.8kgS
1865-05-05Body mass index (BMI) [Ratio]23.8kg/m2S
1865-05-05Systolic blood pressure118mm[Hg]S
1865-05-05Diastolic blood pressure76mm[Hg]S
1865-05-05Heart rate70/minS
1865-05-05Respiratory rate14/minS
1865-05-05Body temperature36.7CelS
1865-05-05Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1865-05-05lamoTRIgine [Mass/volume] in Serum or Plasma6.2ug/mL2.5-15 ug/mLNormalS
1865-05-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Physical Exam

Vital signs recorded on 1865-05-05; see the Vital Signs section. [S]

SystemFinding
GeneralWell and relaxed; weight 68.8 kg; blood pressure 118/76, heart rate 70
SkinNo rash on the trunk, limbs, or face
MouthNo ulcers
NeurologicalNo nystagmus or ataxia; tandem gait normal
PsychiatricEuthymic; organized; good insight

Problems

ProblemClinical statusVerificationCodeProvenance
Epilepsy of unknown type with recurrent generalized tonic-clonic seizures of unknown onset, untreated for many years; etiology unknownactiveconfirmed G40.909S — Synthetic modern coding of his documented epilepsy. The seizure type is left as unknown onset under the ILAE classification, because the retrospective classifications are disputed; no focal or generalized syndrome is coded.
Gambling disorder (roulette, in person and online), moderate, with debtsactiveconfirmed F63.0S — Synthetic modern coding of his documented compulsive roulette gambling.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationSeizure frequency, seizure diary, and seizure descriptionEvery visitCompleted todayOne seizure in week three of the titration after sleep loss; none since reaching 150 mg a day
Medication safetyAntiseizure medicine adverse effects (dizziness, double vision, unsteadiness, sleep, mood)Every visitCompleted todayNo dizziness, double vision, unsteadiness, or sleep change
Medication safetyRash and mouth-sore check (lamotrigine)Every contact during titration and the first two months, then with symptomsCompleted todayNo rash or mouth sores
Medication safetyContact at each lamotrigine dose step to check for rashAt each dose increase during titrationDeferredNo contact was scheduled during the six-week titration, a deviation from the plan to check for rash at each dose step. He knew to stop and call for any rash, and none occurred, so no harm resulted. Corrective action: a nurse telephone check at each step of any future titration
Medication safetyAdherence and missed dosesEvery visitCompleted todayNo missed doses; pill organizer and phone alarms
LaboratoryLamotrigine trough levelOnce at steady state as a reference, then with breakthrough seizures, suspected nonadherence, or interacting medicinesCompleted today6.2 ug/mL trough at steady state; recorded as his reference level
ImagingEEG (routine, then sleep-deprived if normal)At diagnosisUp to dateSleep-deprived EEG six weeks ago normal, with no epileptiform discharges
Self-managementTrigger review: sleep loss, alcohol, overwork, missed dosesEvery visitCompleted todayThe titration seizure followed a night without sleep; he now stops writing by midnight
Self-managementSeizure safety and driving counselingAt diagnosis and every visitCompleted todayNot driving; precautions followed
Self-managementWritten seizure action plan for the people around himAt diagnosis, then yearlyUp to dateUsed by a friend during the seizure in March
SurveyDepression screen (PHQ-9)At intake, then every two to four months while symptoms are presentCompleted todayPHQ-9 6, item 9 scored 0
SurveySuicide-risk review and safety plan, with the 988 Suicide & Crisis LifelineEvery visit (gambling disorder and antiseizure-medicine labeling)Completed todayNo thoughts of suicide
SurveyGambling since the last visit: days, money lost, and urges (G-SAS for the past week)Every visitCompleted todayNo gambling for nine weeks; G-SAS 14 for the past week, from urges only
Self-managementCognitive behavioral therapy for gambling disorderWeekly sessions for at least 8 to 12 weeks, then as neededCompleted todayWeekly, with every session attended
Self-managementSelf-exclusion from casinos and online gamblingAt the start of treatment; renew and extend after any lapseUp to dateIn place
Self-managementFinancial safeguards (bank gambling block, co-signer for large withdrawals, limited cash)At the start of treatmentUp to dateBank block and co-signer in place
ReferralPeer support (Gamblers Anonymous)Offered at the start of treatment and after any lapseCompleted todayTwo Gamblers Anonymous meetings attended
ReferralDebt counselingOnce, early in treatmentCompleted todaySeen; repayment plan being drawn up
Medication safetyMedicine for gambling disorder (opioid antagonist)Considered if psychological treatment alone is not enoughNot indicatedResponding to psychological treatment

Goal progress:

Guideline basis: Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015); Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018); Psychological therapies for pathological and problem gambling (2012); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Four-month review. Call the same day for a rash or a seizure. Next scheduled visit 1865-07-07: four-month review of seizure control, mood, and gambling recovery. [S]